Smiddy W E, Isernhagen R D, Michels R G, Glaser B M, de Bustros S N
Vitreoretinal Surgery Service, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Retina. 1988;8(2):88-95.
The results and complications of pars plana vitrectomy for nondiabetic vitreous hemorrhage due to retinal and choroidal vascular disorders were studied in 68 eyes of 66 patients. Diagnoses included: retinal branch vein obstruction (34 eyes), choroidal neovascularization (15 eyes), central retinal vein occlusion (5 eyes), Eales' disease (10 eyes), pars planitis (3 eyes), and hemoglobin S-C retinopathy (1 eye). The duration of the vitreous hemorrhage was 6 months or more in 48 eyes (71%), and averaged 17.8 months. Preoperative visual acuity was less than 5/200 in 57 eyes (84%). Best postoperative visual acuity was 5/200 or better in 55 patients (81%), and vision improved two or more lines after vitrectomy in 54 eyes (80%). Patients with retinal branch vein obstruction, Eales' disease, or pars planitis had the best prognosis. Those with central retinal vein obstruction or choroidal neovascularization had the worst prognosis.
对66例患者的68只眼进行了研究，以探讨因视网膜和脉络膜血管疾病导致的非糖尿病性玻璃体积血行玻璃体切割术的结果及并发症。诊断包括：视网膜分支静脉阻塞（34只眼）、脉络膜新生血管形成（15只眼）、视网膜中央静脉阻塞（5只眼）、伊尔斯病（10只眼）、睫状体扁平部炎（3只眼）和血红蛋白S-C视网膜病变（1只眼）。48只眼（71%）的玻璃体积血持续时间为6个月或更长，平均为17.8个月。术前视力低于5/200的有57只眼（84%）。术后最佳视力在55例患者中为5/200或更好（81%），54只眼（80%）在玻璃体切割术后视力提高了两行或更多。视网膜分支静脉阻塞、伊尔斯病或睫状体扁平部炎患者的预后最佳。视网膜中央静脉阻塞或脉络膜新生血管形成患者的预后最差。
